Whitehawk Therapeutics (WHWK) Depreciation and Depletion (2016 - 2026)
Whitehawk Therapeutics (WHWK) reported Depreciation and Depletion of $1000.0 for Q1 2026, down 98.25% year-over-year from $57000.0 in Q1 2025, and down 82.14% quarter-over-quarter from $5600.0 in Q3 2025.
Whitehawk Therapeutics (WHWK) Depreciation and Depletion (2016 - 2026) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 10 years of Depreciation and Depletion data on file, last reported at $1000.0 in Q1 2026.
- Depreciation and Depletion for Q1 2026 came in at $1000.0, down 98.25% year-over-year; the trailing twelve-month figure through Mar 2026 was $21900.0 (down 91.35% YoY), and the FY2025 annual result was $100000.0, down 50.0% from the prior year.
- Depreciation and Depletion declined to $1000.0 in Q1 2026 per WHWK's latest filing, from $5600.0 in the prior quarter.
- Over five years, Depreciation and Depletion peaked at $100000.0 in Q4 2023 and troughed at $1000.0 in Q1 2026.
- A 4-year average of $45850.0 and a median of $45350.0 in 2023 frame the typical range for Depreciation and Depletion.
- The sharpest annual moves came in 2024 and 2026: Depreciation and Depletion surged 31.58% in 2024, then plunged 98.25% in 2026.
- A 4-year view of Depreciation and Depletion shows it stood at $100000.0 in 2023, then changed by 0.0% to $100000.0 in 2024, then plunged by 94.4% to $5600.0 in 2025, then plunged by 82.14% to $1000.0 in 2026.
- Business Quant data shows WHWK's Depreciation and Depletion at $1000.0 in Q1 2026, $5600.0 in Q3 2025, and $15300.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 1,395.22 |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Whitehawk Therapeutics | 288.03 Mn | 164.98 Mn | - | 1,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,000.00 |
| Mar 31, 2026 | 1,000.00 |
| Sep 30, 2025 | 5,600.00 |
| Sep 30, 2025 | 5,600.00 |
| Jun 30, 2025 | 15,300.00 |
| Jun 30, 2025 | 15,300.00 |
| Mar 31, 2025 | 57,000.00 |
| Mar 31, 2025 | 57,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Sep 30, 2024 | 46,700.00 |
| Sep 30, 2024 | 46,700.00 |
| Jun 30, 2024 | 49,600.00 |
| Jun 30, 2024 | 49,600.00 |
| Mar 31, 2024 | 50,000.00 |
| Mar 31, 2024 | 50,000.00 |
| Dec 31, 2023 | 100,000.00 |
| Dec 31, 2023 | 100,000.00 |
| Sep 30, 2023 | 44,000.00 |
| Sep 30, 2023 | 44,000.00 |